Resultados de la búsqueda

Quarta CC, Fontana M, Damy T, Catini J, Simoneau D, Mercuri M, Garcia-Pavia P, Maurer MS, Palladini G. Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. Front Cardiovasc Med (2022) 9
Link to the full text in Repisalud

Orrantia A, Vázquez-De Luis E, Astarloa-Pando G, Terrén I, Amarilla-Irusta A, Polanco-Alonso D, González C, Uranga A, Carrascosa T, Mateos-Mazón JJ, García-Ruiz JC, Callejas S, Quintas A, Dopazo A, Zenarruzabeitia O, Borrego F. In vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation. iScience (2022) 25:105235
Link to the full text in Repisalud

Nuche J, de la Cruz Bertolo J, Marco Clement I, Sánchez VS, Sarnago Cebada F, Mancebo E, Enguita AB, Alonso-Riaño M, Ruiz-Hurtado G, López-Azor JC, Hernández-Pérez FJ, Castrodeza J, Sánchez González J, Arribas Ynsaurriaga F, García-Cosío Carmena MD, Delgado JF. Rationale and Protocol of the Multimodality Evaluation of Antibody-Mediated Injury in Heart Transplantation (LEONE-HT) Observational Cross-Sectional Study. Methods Protoc (2022) 5:75
Link to the full text in Repisalud

Polo-Generelo S, Torres B, Guerrero-Martínez JA, Camafeita E, Vázquez J, Reyes JC, Pintor-Toro JA. TGF-β-Upregulated Lnc-Nr6a1 Acts as a Reservoir of miR-181 and Mediates Assembly of a Glycolytic Complex. Noncoding RNA (2022) 8:62
Link to the full text in Repisalud

Guerrero A, Innes AJ, Roux PF, Buisman SC, Jung J, Ortet L, Moiseeva V, Wagner V, Robinson L, Ausema A, Potapova A, Perdiguero E, Weersing E, Aarts M, Martin N, Wuestefeld T, Muñoz-Cánoves P, de Haan G, Bischof O, Gil J. 3-deazaadenosine (3DA) alleviates senescence to promote cellular fitness and cell therapy efficiency in mice. Nat Aging (2022) 2:851-+
Link to the full text in Repisalud

Jensen DM, Skovsted GF, Bonde MFB, Bentzon JF, Rolin B, Franck G, Ougaard MKE, Voetmann LM, Bachmann JC, Uryga A, Pyke C, Kirk RK, Hvid H, Knudsen LB, Lykkesfeldt J, Nyberg M. Semaglutide treatment attenuates vessel remodelling in ApoE-/- mice following vascular injury and blood flow perturbation. Atheroscler Plus (2022) 49:32-41
Link to the full text in Repisalud

Ovejero-Paredes K, Díaz-García D, Mena-Palomo I, Marciello M, Lozano-Chamizo L, Morato YL, Prashar S, Gómez-Ruiz S, Filice M. Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents. Biomater Adv (2022) 137
Link to the full text in Repisalud